Both renal specific medications (e.g. phosphate binders, erythropoietin) [23], [34], [36], [43], and other generic/non-renal medications (e.g. medication for extra-renal morbidity such as hypertension) [36] were studied. Here, EPO is linked to hypertensive disorder.